Position in ARGX
as of Mar 31, 2026
· filed Apr 14, 2026
Position Value
$20,709,159
-$5,318,242 QoQ
Shares Held
28,359
-8.4% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.33%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ARGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Perpetual Ltd holds $140,374,445 across 12 Biotechnology names. ARGX ranks #5 (14.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JAZZ |
Jazz Pharmaceuticals plc
|
140,885 | $26,634,309 | |
| 2 | INSM |
INSMED Inc
|
142,580 | $23,314,680 | |
| 3 | ASND |
Ascendis Pharma A/S
|
100,638 | $23,018,929 | |
| 4 | ARQT |
Arcutis Biotherapeutics, Inc.
|
909,546 | $21,428,903 | |
| 5 | ARGX |
Argenx SE
This page
|
28,359 | $20,709,159 | |
| 6 | GMAB |
Genmab A/S
|
758,503 | $20,350,635 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,145 | $1,657,312 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,690 | $890,040 |
All Filings in ARGX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $20,709,159 | 28,359 | Shares | Defined | 2026-04-14 | |
| 2025-12-31 | $26,027,401 | 30,950 | Shares | Defined | 2026-01-20 | |
| 2025-09-30 | $36,419,974 | 49,379 | Shares | Defined | 2025-10-10 | |
| 2025-06-30 | $53,443,534 | 96,955 | Shares | Defined | 2025-07-11 | |
| 2025-03-31 | $67,786,297 | 114,530 | Shares | Defined | 2025-04-24 | |
| 2024-12-31 | $74,362,110 | 120,914 | Shares | Defined | 2025-01-17 | |
| 2024-09-30 | $76,314,021 | 140,780 | Shares | Defined | 2024-10-09 | |
| No filing history on record for this holder in this stock. | ||||||